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Background: It is important to understand the risk factors for fetal and neonatal mortality which is a major
contributor to high under five deaths globally. Fetal and neonatal mortality is a sensitive indicator of maternal
health in society. This study aimed to examine the risk factors for fetal and early neonatal mortality at the Moi
Teaching and Referral Hospital in Kenya.
Methods: This was a case-control study. Cases were fetal and early neonatal deaths (n = 200). The controls were
infants born alive immediately preceding and following the cases (n = 400). Bivariate comparisons and multiple
logistic regression analyses were undertaken.
Results: The odds of having 0-1 antenatal visits relative to 2-3 visits were higher for cases than controls (Adjusted
Odds Ratio (AOR) = 4.5; 95% CI: 1.2-16.7; p = 0.03)). There were lower odds among cases of having a doctor rather
than a midwife as a birth attendant (AOR = 0.2; 95% CI: 0.1-0.6; p < 0.01). The odds of mothers having Premature
Rupture of Membranes (AOR = 4.1; 95% CI: 1.4-12.1; p = 0.01), haemorrhage (AOR = 4.8; 95% CI: 1.1-21.9; p = 0.04)
and dystocia (AOR = 3.6; 95% CI: 1.2-10.9; p = 0.02) were higher for the cases compared with the controls. The odds of
gestational age less than 37 weeks (AOR = 7.0; 95% CI 2.4-20.4) and above 42 weeks (AOR = 16.2; 95% CI 2.8-92.3)
compared to 37-42 weeks, were higher for cases relative to controls (p < 0.01). Cases had higher odds of
being born with congenital malformations (AOR = 6.3; 95% CI: 1.2-31.6; p = 0.04) and with Apgar scores of below
six at five minutes (AOR = 26.4; 95% CI: 6.1-113.8; p < 0.001).
Conclusion: Interventions that focus on educating mothers on antenatal attendance, screening, monitoring and
management of maternal conditions during the antenatal period should be strengthened. Doctor attendance
at each birth and for emergency admissions is important to ensure early neonatal survival and avert potential
risk factors for mortality.
Keywords: Early neonatal mortality, Fetal death, Risk factors, Maternal, Tertiary hospitalBackground
Neonatal death is defined as newborn death occurring
within the first four weeks after birth [1]. Neonatal deaths
represent 40% of under-five deaths worldwide [2,3]. Des-
pite the reduction in overall under five mortality in devel-
oping regions, from 97 deaths per 1000 live births in 1990
to 63 per 1000 live births in 2010, there has been little
change in neonatal deaths as a proportion of under five
deaths [2,3]. In Sub-Saharan Africa, for example, the pro-
portion of neonatal deaths among under five deaths* Correspondence: yegofaith@gmail.com
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unless otherwise stated.increased from 37% in 1990 to 40% in 2010 [2,3]. Neonatal
mortality rates in the developing world are generally high,
for example, there were 32 deaths per 1000 live births in
Central Africa in 2009 [4], and in Somalia the estimated
neonatal mortality rate was 52 per 1000 live births in 2012
[5]. In comparison, the neonatal mortality rate in Kenya is
currently 28 per 1000 live births and there has been little
progress towards achieving the Millennium Development
Goal (MDG) Four for child survival [2,6]. The main
direct causes of neonatal deaths globally are preterm
births (27%), severe infections (26%), asphyxia (23%),
and neonatal tetanus (7%) [3,7,8].
Early neonatal death is defined as all deaths of live-born
infants occurring on or before the first seven days of lifehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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reduction in early neonatal mortality over the past decade
[2]. Most programs addressing childhood mortality focus
on pneumonia, malaria, diarrhoea and vaccine preventable
conditions, which are geared towards improving child sur-
vival after the first four weeks of life [5,6]. There is evi-
dence that the highest numbers of early neonatal deaths in
Sub-Saharan Africa are due to infections [10,11].
Fetal death is defined as any fetus born without a heart-
beat, respiratory effort or movement, or any other sign of
life [9]. It is estimated that globally 2.9 million babies ex-
perience fetal death or die within the first week of life,
with 99% of these deaths occurring in developing coun-
tries [12]. Studies have shown that 50% of maternal deaths
occur within the first day after childbirth and approxi-
mately 30% of stillbirths occur during labour [5].
The health and survival of newborns has been shown to
be closely linked to that of their mothers, since inadequate
maternal care during the pregnancy and postpartum period
can also affect the neonate [13]. It has been suggested that
access to antenatal care and emergency obstetric care could
reduce neonatal mortality by 10-15% [5,14]. There is evi-
dence that 10% of intrapartum-related and preterm deaths
can be reduced by immediate assessment and stimulation
of newborns [15]. Treatment with antenatal corticoste-
roids has been associated with a decrease in overall
neonatal deaths, especially for women with premature
rupture of membranes (PROM) [16].
Health system factors have been associated with new-
born deaths, especially in low resource settings where
quality of care is generally poor and inadequate [17]. An
assessment of six African countries showed that less than
12% of personnel working in health facilities were trained
to conduct neonatal resuscitation and no more than 22%
of the facilities had sufficient equipment for neonatal re-
suscitation [18].
Due to these high mortality rates it is important to
understand the risk factors for fetal and neonatal mortality
which are major contributors to high under five deaths glo-
bally. Fetal and neonatal mortality is also a sensitive indica-
tor of maternal health in society because healthy mothers
give birth to healthy babies. This study was undertaken to
assess maternal and neonatal risk factors associated with
fetal and early neonatal deaths in the second largest tertiary
hospital in Kenya in order to provide insights into the
circumstances surrounding fetal and early neonatal deaths.
Methods
This retrospective case-control study was conducted in
Moi Teaching Referral Hospital (MTRH) in Kenya. The
study was undertaken in Uasin Gishu County which is
in the Rift Valley Province of Kenya. This hospital ser-
vices approximately seven million women [19]. The MTRH
has a reproductive health wing called the Riley MotherBaby Unit, which contains both the labour ward and the
New Born Unit (NBU). The NBU has three sections: the
born before arrival (BBA) unit, the acute ward or critical
ward and the general ward [20]. The NBU has several incu-
bators, newborn trolleys, a capacity of 60 beds, and is
staffed with consultant paediatricians (10), registrars (6),
intern doctors (one) and nurses (30) specially trained for
NBU care [20]. According to the MTRH records depart-
ment the total number of monthly admissions during the
study period was about 120-140 newborns [20].
Client flow in the hospital is such that pregnant/post-
partum patients are seen in a designated room (triage
area) on the labour ward floor by a nurse, medical officer
intern and resident doctor. Patients in active labour are
usually admitted to the labour ward where they are man-
aged by a team of obstetricians, residents, interns and
midwives/nurses. Patients in a latent phase of labour,
or with medical conditions, are usually admitted to the
antenatal ward, and other patients with medical issues
after delivery are admitted to the post natal ward. Patients
without complications are discharged. Neonates who
have complications after birth are immediately taken to
the NBU which is adjacent to the labour ward. The neo-
natologist and paediatricians subsequently manage the
neonate [20].
A medical record review was undertaken on admis-
sions to the newborn unit in MTRH between January
2005 and March 2011. Cases were defined as neonates
who were born dead (fetal deaths) or died within seven
days of birth (early neonatal deaths). Most recent cases
were selected retrospectively until the desired sample
size was achieved. Two controls were obtained for every
case. The controls were surviving neonates born imme-
diately preceding and following the cases within the first
week of life. Exclusion criteria were late neonatal deaths
(more than seven days after birth).
A structured data collection instrument was used to
collect data from medical records identified from the
NBU admission register. It was not possible to blind the
data abstractors to case/control status because mortality
information was in the medical records.
The primary cause of death was identified using the infor-
mation from hospital medical records and post mortem re-
ports. Where interpretation was required, the information
on the cause of death was verified by the study physician.
Data were coded and double entered into two separate
password protected databases, which were later compared
for consistency. Where there were inconsistencies, the pa-
tient’s file was obtained to verify the information.
The outcome of this study was death of the neonate or
fetus at birth or within seven days of birth. Explanatory
variables were classified as maternal and obstetric char-
acteristics, maternal and obstetric complications, neonatal
complications and neonatal characteristics.
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mation on women of reproductive age (15 to 49 years)
such as: mother’s age (15-24 years, 25-34 years, or 35-45
years); gravidity categorised as primigravida (1), multigrav-
ida (2-4), or grandmultigravida (above 5); qualification of
birth attendant (doctor (consultant/registrar/intern), or
midwife); gestational age (less than 37 weeks, 37-42 weeks
or above 42 weeks); mode of delivery (spontaneous vertex
delivery, assisted vaginal delivery, or caesarean section);
number of antenatal visits (ANC) (0-1, 2-3, or above 4),
and booking status on admission (yes = attended ANC at
MTRH or no = did not attend ANC at MTRH).
Maternal and obstetric complications included the pres-
ence of common causes of death, as documented in the
patient records and post mortem reports; premature rup-
ture of membranes (PROM); dystocia (prolonged or
obstructed labour); pre-eclampsia; haemorrhage; and other
complications (cardio respiratory diseases, previous scar,
Human Immunodeficiency Virus or HIV, malaria, retained
placenta, anaemia, abortion). A complication was assumed
there was an indication to this effect in the notes, otherwise
it was assumed that there were no complications.
Newborn complications included the presence of causes of
newborn death as documented in the records including as-
phyxia, congenital malformation, sepsis, Respiratory Distress
Syndrome (RDS), and other complications (hypothermia,
diarrhoea, jaundice, hypoglycaemia, meconium aspiration
syndrome, and HIV). One single cause of death was iden-
tified for each neonate case and where there were multiple
causes the final cause of death documented in the post
mortem reports was used.
Neonatal characteristics including sex, Apgar score at
five minutes and weight in grams were also recorded.
Ethical approval was provided by the University of
Newcastle Human Research Ethics Committee (HREC) and
the Institutional Research and Ethics Committee (IREC)
in Kenya. Permission was obtained from the MTRH ad-
ministration to undertake the study.
Statistical methods
Statistical analysis was performed using STATA version
10 (StataCorp, College Station, TX, USA). Exploratory
data analysis involved checking the data for implausible
relationships, outliers and errors using frequency distri-
butions, tables and graphs. Checks comprised visualizing
the distributions by use of graphics including histograms
overlaid with a normal curve, normal probability plots and
box plots to identify potential errors. Bar charts were also
used to compare distributions between groups.
All variables were categorical. Categories were combined
where cell sizes were small. Bivariate analysis was under-
taken using the Chi-squared test to compare characteris-
tics of cases and controls. Initially, a modelling process
was undertaken by including all variables with p < 0.2 inseparate models for each of the four groups of potential
risk factors (maternal and obstetric characteristics, neo-
natal complications, maternal and obstetric complications
and neonatal characteristics). Each group of potential risk
factors was analysed in separate multivariable logistic re-
gression. A backward stepwise method was used whereby,
at each step, variables with a p-value of >0.1 on the likeli-
hood ratio test were removed. The remaining variables
were combined in a final model. Unadjusted and adjusted
odds ratios, confidence intervals and p-values are reported
for all models.
For a ratio of cases to controls of 1:2, 80% power, a 5%
significance level and 40% probability of exposure (i.e. risk
factor prevalence) in controls, a sample of 600 neonates
(200 cases and 400 controls) was required to detect an ab-
solute difference in risk factor prevalence of at least 12%,
or an odds ratio of approximately 0.6 or 1.7.
Results
A total of 600 records were reviewed (200 cases and 400
controls) from January 2005 to March 2011. As with
many studies using data abstracted from medical re-
cords, data were incomplete in some areas. The propor-
tion of missing data in variables ranged from 0.3% to
22%. Data were separately stored in the MTRH neonatal
and maternal records. Missing data in individual records
arose from one or both sources.
Table 1 shows the maternal and obstetric factors asso-
ciated with fetal and early neonatal mortality at MTRH.
Gestational age at admission (p < 0.001), number of ante-
natal visits (p < 0.001) and qualification of birth attendant
(p = 0.01) were all significantly associated with fetal and
early neonatal mortality. The odds of gestational period
below 37 weeks, relative to gestational age of 37-42 weeks
were higher for cases than controls (Adjusted Odds Ratio
(AOR) = 16.6; 95% CI: 8.2-33.7). The odds of having 0-1
antenatal visits relative to 2-3 visits were higher for cases
than controls (AOR = 5.4; 95% CI: 2.0-14.7). Compared to
controls, cases had lower odds of having four or more
antenatal visits relative to 2-3 visits (AOR = 0.3; 95% CI:
0.1-0.7); and having a birth attendant who was a doctor
rather than a midwife (AOR = 0.4; 95% CI: 0.2-0.8).
Maternal obstetric complications associated with fetal
and early neonatal mortality at MTRH are shown in Table 2.
PROM, haemorrhage, and dystocia were significantly as-
sociated with mortality. Compared with the controls, the
cases had higher odds of maternal PROM (AOR= 5.9;
95% CI: 3.5-9.9; p < 0.001), dystocia (AOR = 1.9; 95% CI:
1.2-3.1; p = 0.01), and haemorrhage (AOR = 2.4; 95% CI:
1.2-4.7; p = 0.02). Cases had higher odds of other compli-
cations compared with controls (AOR =2.0; 95% CI: 1.0-
3.9; p = 0.06) although the difference was not significant.
Table 3 shows the association between neonatal compli-
cations with fetal and early neonatal mortality at MTRH.
Table 1 Association between maternal and obstetric factors with fetal and early neonatal death at MTRH from Jan
2005-Mar 2011
Predictor Cases n (%) Controls n (%) Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
p-value for likelihood ratio test
Age in years 0.98
15-24 97 (51) 195 (49) 1.0 1.0
25-34 68 (35) 172 (43) 0.8 (0.5-1.2) 1.1 (0.5-2.3)
35-45 27 (14) 33 (8) 1.6 (0.9-2.9) 1.1 (0.3-4.0)
Gravidity 0.26
Multigravida 108 (54) 231 (58) 1.0 1.0
Primigravida 58 (29) 119 (30) 1.0 (0.7-1.5) 0.8 (0.4-1.9)
Grandmultigravida 34 (17) 50 (12) 1.5 (0.9-2.4) 2.3 (0.8-6.6)
Qualification of birth attendant 0.01
Midwife 142 (74) 191 (50) 1.0 1.0
Doctor 50 (26) 187 (49) 0.4 (0.2-0.5) 0.4 (0.2-0.8)
Gestational age at admission <0.001
<37 weeks 116 (72) 74 (20) 11.0 (7.1-17.2) 16.6 (8.2-33.7)
37-42 weeks 39 (24) 274 (75) 1.0 1.0
> 42 weeks 6 (4) 15 (4) 2.8 (1.0-7.7) 2.4 (0.4-13.4)
Mode of delivery 0.79
Normal 146 (73) 249 (62) 1.0 1.0
Assisted 9 (5) 13 (3) 1.2 (0.5-2.8) 1.5 (0.3-7.9)
45 (22) 138 (35) 0.6 (0.4-0.8) 1.3 (0.5-3.1)
Number of antenatal care visits <0.001
0-1 31 (26) 15 (4) 5.9 (3.0-11.6) 5.4 (2.0-14.7)
2-3 74 (63) 212 (59) 1.01 1.0
Above 4 13 (11) 133 (36) 0.3 (0.1-0.5) 0.3 (0.1-0.7)
Booking status 0.28
No 139 (79) 311 (80) 1.0 1.0
Yes 38 (21) 80 (20) 0.9 (0.6-1.5) 0.9 (0.5-2.2)
Reference category represented by 1.0.
Numbers may not add to total sample size due to missing values.
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0.001), congenital malformation (AOR 2.9; 95% CI: 1.5-
5.7; p = 0.01) and RDS (AOR 1.6; 95% CI: 1.1-2.4; p =
0.01), were higher for cases relative to controls. The odds
of sepsis were marginally non-significantly lower for cases
than controls (AOR = 0.7; 95% CI: 0.4-1.0; p = 0.06).
The association between neonatal characteristics and
early neonatal mortality at MTRH is shown in Table 4.
Baby’s birth weight and Apgar score were significantly
associated with mortality (p < 0.001 for both). Relative to
controls, cases had higher odds of birth weight less than
2500 grams (AOR 6.6; 95% CI: 3.8-10.2) and an Apgar
score of zero to six (AOR 13.4; 95% CI 7.3-24.8) rather
than seven or above at five minutes.
Table 5 represents the final model combining factors
from the four previous models. The odds of having a
birth attendant who was a doctor versus a midwife werelower for cases relative to controls (AOR = 0.2; 95% CI:
0.1-0.6; p < 0.01). Cases, compared to controls, had higher
odds of having mothers who had 0-1 antenatal visit rela-
tive to 2-3 visits (AOR = 4.5; 95% CI: 1.2-16.7; p = 0.03
overall). The odds of gestational age less than 37 weeks
(AOR = 7.0; 95% CI 2.4-20.4) and above 42 weeks (AOR =
16.2; 95% CI 2.8-92.3), rather than 37-42 weeks were
higher for cases relative to controls (p < 0.01). The odds of
mothers with complications of PROM (AOR = 4.1; 95%
CI: 1.4-12.1; p = 0.01), haemorrhage (AOR = 4.8; 95% CI:
1.1-21.9; p = 0.04) or dystocia (AOR = 3.6; 95% CI: 1.2-
10.9; p = 0.02) were higher for cases relative to controls.
Cases, compared to controls had higher odds of being
born with congenital malformations (AOR = 6.3; 95% CI:
1.2-31.6; p = 0.04), and being born with Apgar scores of
0-6 (AOR = 26.4; 95% CI: 6.1-113.8; p < 0.001), rather
than a score of above seven at five minutes.
Table 2 Association between maternal obstetric complications with fetal and early neonatal mortality at MTRH from
Jan 2005-Mar 2011
Predictor Cases n (%) Controls n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value for likelihood ratio test
Premature rupture of membranes <0.001
Yes 52 (26) 27 (7) 4.9 (2.9-8.0) 5.9 (3.5-9.9)
No 148 (74) 373 (93) 1.0 1.0
Dystocia 0.01
Yes 42 (21) 64 (16) 1.4 (0.9-2.2) 1.9 (1.2-3.1)
No 158 (79) 336 (84) 1.0 1.0
Pre-eclamspia 0.44
Yes 13 (7) 29 (7) 1.0 (0.5-1.8) 1.3 (0.7-2.7)
No 187 (93) 371 (93) 1.0 1.0
Haemorrhage 0.02
Yes 17 (9) 21 (5) 1.7 (0.9-3.3) 2.4 (1.2-4.7)
No 183 (91) 379 (95) 1.0 1.0
Other complications 0.06
Yes 16 (8) 22 (6) 1.5 (0.8-2.9) 2.0 (1.0-3.9)
No 184 (92) 378 (94) 1.0 1.0
Reference category for logistic regression represented by 1.0.
Other complications included: cardio respiratory diseases, previous scar, HIV, malaria, retained placenta, anaemia, abortion.
Numbers may not add to total sample size due to missing values.
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This study examined risk factors associated with fetal and
early neonatal mortality at MTRH. Factors that were signifi-
cantly associated with early neonatal mortality in adjusted
analyses were: qualification of the birth attendant; gestationalTable 3 Association between neonatal complications with fet
2005-Mar 2011
Predictor Cases n (%) Controls n (%) U
(
Asphyxia
Yes 73 (37) 74 (19) 2
No 127 (63) 326 (81) 1
Congenital malformation
Yes 21 (11) 18 (5) 2
No 179 (89) 182 (95) 1
Sepsis
Yes 37 (18) 125 (31) 0
No 163 (82) 275 (69) 1
Respiratory Distress syndrome
Yes 66 (33) 94 (24) 1
No 134 (67) 306 (76) 1
Other neonatal complications
Yes 32 (16) 79 (20) 0
No 168 (84) 321 (80) 1
Reference category for logistic regression represented by 1.0.
Other complications included: hypothermia, diarrhoea, jaundice, hypoglycaemia, m
Numbers may not add to total sample size due to missing values.age; number of antenatal visits; maternal complication at
birth (PROM, haemorrhage and dystocia); congenital mal-
formations, and low Apgar scores at five minutes.
The odds of low ANC attendance (0-1 visit) were higher
for cases relative to controls. This is possibly because feweral and early neonatal mortality at MTRH from Jan
nadjusted OR
95% CI)
Adjusted OR
(95% CI)
p-value for likelihood ratio test
<0.001
.5 (1.7-3.7) 2.4 (1.6-3.6)
.0 1.0
0.01
.5 (1.3-4.8) 2.9 (1.5-5.7)
.0 1.0
0.06
.5 (0.3-0.8) 0.7 (0.4-1.0)
.0 1.0
0.01
.6 (1.1-2.3) 1.6 (1.1-2.4)
.0 1.0
0.50
.8 (0.5-1.2) 0.9 (0.5-1.4)
.0 1.0
econium aspiration syndrome, sero-exposed.
Table 4 Association between neonatal characteristics with fetal and early neonatal mortality at MTRH from Jan
2005-Mar 2011
Predictor Cases n (%) Controls n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value for likelihood ratio test
Baby’s birth weight <0.001
less than 2500 gms 133 (73) 116 (29) 6.6 (4.5-9.8) 6.6 (3.8-10.2)
Above 2500 gms 49 (27) 282 (71) 1.0 1.0
Baby’s Apgar score <0.001
0-6 at 5 mins 78 (49) 20 (5) 17.2 (10.0-29.8) 13.4 (7.3-24.8)
7-10 at 5 mins 79 (50) 349 (95) 1.0 1.0
Baby’s sex
Female 85 (44) 190 (48) 0.9 (0.6-1.3) 1.0 (0.6-1.7) 0.88
Male 105 (55) 208 (52) 1.0 1.0
Reference category for logistic regression represented by 1.0.
Numbers may not add to total sample size due to missing values.
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nancy and failure to prevent, detect, and manage maternal
conditions during the pregnancy. These issues have been
reported by other studies in developing countries [19,21].
Moreover, since reasons for low ANC attendance could in-
clude lack of education, lack of female empowerment, and
poverty, these factors may also explain some of the rela-
tionship between ANC attendance and fetal and early neo-
natal mortality [22]. Additionally, recent research has
indicated that timing of visits is more important in detect-
ing complications than the number of visits [23], hence
women who only had 0-1 visit may have been prompted
by a problem with their pregnancy rather than continuous
monitoring of the pregnancy. The timing of ANC was
however not captured in our study.
Assistance from a doctor (consultant, registrar or med-
ical officer intern) was protective against neonatal mor-
tality. This finding is in agreement with other studies
that have found the presence of a doctor at birth en-
hances appropriate management and reduces maternal
and infant mortality [1,21,24]. Lack of emergency obstet-
ric care increases the risk of neonatal mortality. This is
because labouring mothers cannot always access appro-
priate health services.
Maternal complications that were risk factors for fetal
and early neonatal mortality were: PROM, dystocia, and
haemorrhage. Mothers with PROM have been previously
shown to be more likely to deliver preterm babies than
those without this condition, with both maternal and
neonatal risk of infection higher for this group [25]. This
is concerning as infections are the leading cause of neonatal
death in Sub-Saharan Africa [1,10,25]. Dystocia (prolonged
or obstructed labour) was also a significant risk factor for
mortality and this is consistent with another study which
found that dystocia may result in the fetus having asphyxia
[26]. Haemorrhage can be rapidly fatal to both the mother
and neonate before medical intervention can be institutedand it has been reported as one of the leading causes of
neonatal mortality in developing countries [27].
Babies born before or after 37-42 weeks carry signifi-
cant risks during, and immediately after delivery and
may require intervention by doctors [4]. The majority of
health facilities in Sub-Saharan Africa lack proper resus-
citation equipment and neonatal intensive support units,
and are thus unable to adequately manage neonates born
prematurely [17,18,28]. Prematurity is among the top
three major causes of neonatal death in developing coun-
tries because of slow progress in uptake of public health
measures such as antenatal corticosteroids, and proper hy-
giene practices during child birth [3,5,28].
The study found that congenital malformation was sig-
nificantly associated with mortality. This is consistent with
another study that reported congenital malformation as
one of the causes of death in developing countries [7].
The presence of congenital anomalies in newborns could
be in part explained by the lack of adequate screening and
detection of these conditions during the antenatal period.
If this had occurred then it may have been possible to give
patients and doctors opportunities to make decisions on
interventions prior to birth [28-30]. Other pre-disposing
factors for congenital anomalies are maternal socio-
economic and nutritional status, the presence of maternal
infections, and environmental exposure to hazardous agri-
cultural chemicals which contribute to about one-third of
the disease burden in Sub-Saharan Africa [31,32].
The majority of neonatal deaths in this study had poor
Apgar scores at five minutes after birth. This is consistent
with other studies that have found a high risk of asphyxia
among babies born to mothers with poor nutritional sta-
tus, lack of ANC, and haemorrhage [21,28,33]. Information
on some Apgar scores was not recorded, perhaps because
of lack of time between transfers from one ward to the
other, especially when the neonates had to be rushed
to the newborn unit for resuscitation. This is a possible
Table 5 Determinants of fetal and early neonatal mortality at MTRH from Jan 2005-Mar 2011
LR test statistic
Predictor Cases n (%) Controls n (%) Adjusted OR (95% CI) x2 Degrees of freedom P value
Qualification of birth attendant 10.58 1 <0.01
Midwife 142 (74) 191 (50) 1
Doctor 50 (26) 187 (49) 0.2 (0.1-0.6)
Number of antenatal care visits 7.35 2 0.03
0-1 31 (26) 15 (4) 4.5 (1.2-16.7)
2-3 74 (63) 212 (59) 1.0
Above 4 13 (11) 133 (36) 0.5 (0.2-1.5)
Gestational age at admission 19.72 2 <0.01
<37 weeks 116 (72) 74 (20) 7.0 (2.4-20.4)
37-42 weeks 39 (24) 274 (75) 1.0
> 42 weeks 6 (4) 15 (4) 16.2 (2.8-92.3)
Premature rupture of membrane 6.38 1 0.01
No 148 (74) 373 (93) 1.0
Yes 52 (26) 27 (7) 4.1 (1.4-12.1)
Haemorrhage 4.09 1 0.04
No 183 (91) 371 (95) 1.0
Yes 17 (9) 29 (5) 4.8 (1.1-21.9)
Dystocia 5.08 1 0.02
No 158 (79) 336 (84) 1.0
Yes 42 (21) 64 (16) 3.6 (1.2-10.9)
Other maternal complications 0.47 1 0.49
No 184 (92) 378 (94) 2.0 (0.3-13.9)
Yes 16 (8) 22 (6) 1.0
Sepsis 0.3 1 0.58
No 163 (82) 275 (69) 1.0
Yes 37 (18) 125 (31) 1.4 (0.5-3.9)
Asphyxia 1.65 1 0.20
No 127 (63) 326 (81) 1.0
Yes 73 (37) 74 (19) 0.4 (0.1-1.7)
Respiratory Distress syndrome 0.05 1 0.82
No 134 (67) 306 (76) 1.0
Yes 66 (33) 94 (24) 0.9 (0.4-2.3)
Congenital malformation 4.14 1 0.04
No 179 (89) 182 (95) 1.0
Yes 21 (11) 18 (5) 6.3 (1.2-31.6)
Baby’s birth weight 2.82 1 0.09
Above 2500 gms 49 (27) 282 (71) 1.0
less than 2500 gms 133 (73) 116 (29) 2.4 (0.9-6.7)
Baby’s Apgar score 26.09 1 <0.001
7-10 at 5 mins 79 (50) 349 (95) 1.0
0-6 at 5 mins 78 (49) 20 (5) 26.4 (6.1-113.8)
Reference category for logistic regression represented by 1.0.
Numbers may not add to total sample size due to missing values.
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larly for the cases, and this may have contributed to the
wide confidence intervals for the estimates.
The findings of this study are not only important for
MTRH, which is Kenya’s second largest hospital, but also
for the Ministry of Health (MOH) in Kenya. They high-
light the importance of informing stakeholders about
areas where services can be improved. These include, for
example, training for newborn care, the provision of ad-
equate supplies and equipment, the development of proto-
cols for newborn management and regular criterion-based
audits aimed at averting early neonatal mortality. Add-
itionally, most recommendations from this study relate to
education and advocacy, issues which are relevant to the
broader community.
One major limitation of this study was that there was
potential selection bias because only hospital births were
included. The sample may not therefore be representa-
tive of all births in the region, because high risk women,
or women who develop complications, may be more
likely to deliver in hospitals. The proportion of Kenyan
women who deliver in community health facilities reported
in the literature is 42.8% [34]. Another potential limitation
is that it was not possible to blind the data abstractors to
case or control status. Also MTRH did not have checklists
or protocols for hospital personnel regarding medical
records. Time pressures on staff were substantial and
there was high patient throughput. The doctor to pa-
tient ratio was approximately 1:5000. It is therefore likely
that some information may have been omitted from pa-
tient records [35].
Conclusions
In conclusion, the risk factors for fetal and early neonatal
mortality included: number of antenatal visits, gestational
age, qualification of the birth attendant, mother’s compli-
cation at birth (PROM, haemorrhage, dystocia), low Apgar
scores at five minutes and congenital malformations. In-
terventions that focus on educating mothers on the im-
portance of antenatal clinic attendance, as well as ensuring
screening, detection, monitoring and management of ma-
ternal conditions during the antenatal period, could help
reduce neonatal mortality rates.
Doctor attendance at birth and during emergencies is im-
portant and can help to ensure that the newborn survives
beyond the first week of their life. There is a need to in-
crease the availability of resuscitation equipment, train
personnel in newborn care and develop and implement
protocols and checklists to promote efficiencies in medical
record information gathering and documentation. Accurate
complete maternal and neonatal records are important for
the delivery of care to both the mother and baby. Combin-
ing maternal and neonatal records is one way of assisting
clinical management and also providing data for research.This research offers some possible reasons for the high
mortality among neonates in a tertiary institution in Kenya.
The findings have relevance for both mothers and neo-
nates. Further research into factors influencing the timing
and uptake of antenatal care by women in the community,
as well as the contribution of quality of care to neonatal
mortality in health facilities, is needed.
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